Man's best friend
A recent discovery in the Atai mountains of southern Siberia has presented some of the oldest known evidence of dog domestication.
A recent discovery in the Atai mountains of southern Siberia has presented some of the oldest known evidence of dog domestication.1
The 33 000-year-old dog skull was found in a cave and was remarkably well-preserved. Skull, mandibles and teeth were present and it was possible to conduct a complete morphological description.
The team used an accelerator mass spectrometer to confirm the age of the skull by measuring the amount of radioactive carbon in a sample. They performed the experiment in three independent laboratories, which resulted in highly compatible ages, with an average of 33 000 years.
Together with a discovery in Belgium, this is the earliest incipient dog from Western Europe. Prior to this, practically all well-documented remains of early domestic dog come from the late Glacial and early Holocene periods (around 14 000–9 000 calendar years ago), with few found prior to the Last Glacial Maximum (around 26 500–19 000 years ago). The find in Belgium also helps to support the idea that dog domestication was multi-regional and had no single place of origin, as DNA data has suggested in the past.
1. Johannes van der Plicht et al., PLoS ONE, 6(7), e22821 (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
